Magali P. A. Disdier Moulder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Magali P. A. Disdier Moulder has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Abby K. Hendricks
Department of Pharmacy, Mayo Clinic, Rochester, Minnesota
1 shared publication- Abby K. Hendricks
Department of Pharmacy Mayo Clinic College of Medicine and Science, Mayo Clinic Rochester Minnesota USA
1 shared publication - Adelaide M. Arruda-Olson
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
1 shared publication Alisha P. Chaudhry
Department of Cardiovascular Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN
1 shared publication- Ana Isabel Casanegra
Department of Cardiovascular Diseases, Division of Vascular Medicine, Mayo Clinic, Rochester, MN, USA
1 shared publication - Christopher G. Scott
Mayo Clinic
1 shared publication
Latest Publications
- Open Access
- 28 November 2020
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 5 (1) , 94-102
Usability of a Digital Registry to Promote Secondary Prevention for Peripheral Artery Disease Patients
- 28 November 2020
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 5 (1) , 94-102
Open AccessUsability of a Digital Registry to Promote Secondary Prevention for Peripheral Artery Disease Patients
- Open Access
- 11 December 2019
- Published by Wiley in Clinical Cardiology
- Vol. 43 (2) , 137-144
Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?
Background: Polypharmacy in older adults leads to increased risks of side effects and drug‐drug interactions, affecting their health outcomes and quality of life. Deprescribing, the act of simplifying medication regimens, is challenging due to the lack of consensus guidelines.Hypothesis: To offer some guidance on managing medication regimens for older cardiovascular patients.Methods: We reviewed the most recent pertinent guidelines and literature.Results: This review provides practical considerations for appropriate prescribing in the older population with cardiovascular disease in order to strike a balance between unnecessary or harmful medications and therapies with proven long‐term benefits.Conclusion: On‐going dialogue between healthcare providers and patients allows close monitoring of medication effectiveness and prevention of side effects. Medication regimens require individualization, as patients' goals of care change with advancing age.
- 11 December 2019
- Published by Wiley in Clinical Cardiology
- Vol. 43 (2) , 137-144
Open AccessTowards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?
Background: Polypharmacy in older adults leads to increased risks of side effects and drug‐drug interactions, affecting their health outcomes and quality of life. Deprescribing, the act of simplifying medication regimens, is challenging due to the lack of consensus guidelines.Hypothesis: To offer some guidance on managing medication regimens for older cardiovascular patients.Methods: We reviewed the most recent pertinent guidelines and literature.Results: This review provides practical considerations for appropriate prescribing in the older population with cardiovascular disease in order to strike a balance between unnecessary or harmful medications and therapies with proven long‐term benefits.Conclusion: On‐going dialogue between healthcare providers and patients allows close monitoring of medication effectiveness and prevention of side effects. Medication regimens require individualization, as patients' goals of care change with advancing age.